Standout Papers

Recurrent Fusion of <i>TMPRSS2</i> and ETS Transcription Factor Genes in Prosta... 2001 2026 2009 2017 2.8k
  1. Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer (2005)
    Scott A. Tomlins, Daniel R. Rhodes et al. Science
  2. The polycomb group protein EZH2 is involved in progression of prostate cancer (2002)
    Sooryanarayana Varambally, Saravana M. Dhanasekaran et al. Nature
  3. Delineation of prognostic biomarkers in prostate cancer (2001)
    Saravana M. Dhanasekaran, Terrence R. Barrette et al. Nature
  4. EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells (2003)
    Celina G. Kleer, Qi Cao et al. Proceedings of the National Academy of Sciences
  5. Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma (2005)
    Levi A. Garraway, Hans R. Widlund et al. Nature
  6. Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer (2016)
    Himisha Beltran, Davide Prandi et al. Nature Medicine
  7. Increased Expression of Genes Converting Adrenal Androgens to Testosterone in Androgen-Independent Prostate Cancer (2006)
    Glenn J. Bubley, Kenneth N. Ross et al. Cancer Research
  8. Integrative molecular concept modeling of prostate cancer progression (2006)
    Scott A. Tomlins, Rohit Mehra et al. Nature Genetics
  9. Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression (2005)
    Sooryanarayana Varambally, Jianjun Yu et al. Cancer Cell
  10. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer (2007)
    Scott A. Tomlins, Bharathi Laxman et al. Nature
  11. Role of the TMPRSS2-ERG Gene Fusion in Prostate Cancer (2008)
    Scott A. Tomlins, Bharathi Laxman et al. Neoplasia
  12. Meta-analysis of microarrays: interstudy validation of gene expression profiles reveals pathway dysregulation in prostate cancer. (2002)
    Daniel R. Rhodes, Terrence R. Barrette et al. PubMed
  13. Suppression of insulin feedback enhances the efficacy of PI3K inhibitors (2018)
    Benjamin D. Hopkins, Chantal Pauli et al. Nature
  14. Proposed Morphologic Classification of Prostate Cancer With Neuroendocrine Differentiation (2014)
    Jonathan I. Epstein, Mahul B. Amin et al. The American Journal of Surgical Pathology
  15. The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours (2022)
    Holger Moch, Mahul B. Amin et al. European Urology
  16. Patterns of Gene Expression and Copy-Number Alterations in von-Hippel Lindau Disease-Associated and Sporadic Clear Cell Carcinoma of the Kidney (2009)
    Rameen Beroukhim, Arianna Di Napoli et al. Cancer Research
  17. The 2022 World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs—Part B: Prostate and Urinary Tract Tumors (2022)
    George J. Netto, Mahul B. Amin et al. European Urology

Immediate Impact

1 by Nobel laureates 33 from Science/Nature 99 standout
Sub-graph 1 of 21

Citing Papers

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Metabolic reprogramming and cancer progression
2020 StandoutScience
3 intermediate papers

Works of Mark A. Rubin being referenced

Suppression of insulin feedback enhances the efficacy of PI3K inhibitors
2018 StandoutNature
Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma
2005 StandoutNature
and 1 more

Author Peers

Author Last Decade Papers Cites
Mark A. Rubin 22807 26319 13092 545 48.4k
W. Marston Linehan 21208 22532 13176 581 44.8k
David N. Louis 15368 23780 14394 318 62.6k
Matthew Meyerson 19556 33595 13589 277 57.6k
Kenneth J. Pienta 17167 21478 11891 662 48.6k
Holger Moch 14366 17943 9529 602 35.4k
Charles L. Sawyers 15672 24460 9105 263 52.5k
Guido Sauter 9856 17375 7958 595 34.4k
Ming‐Sound Tsao 13475 16214 8193 644 36.3k
Andreas von Deimling 10166 22183 12852 645 57.6k
Massimo Loda 9636 22368 10588 464 39.1k

All Works

Loading papers...

Rankless by CCL
2026